Research and Markets: MediPoint: Nuclear Imaging - Current and Future Players

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/rlz62q/medipoint) has announced the addition of the "MediPoint: Nuclear Imaging - Current and Future Players" report to their offering.

This report examines how new technologies can emerge in the face of economic pressures that may affect the demand for nuclear imaging, and how healthcare reforms are impacting nuclear medicine. The advent of hybrid imaging has enabled PET/CT imaging to undergo explosive growth. However, this has been at the cost of an increased demand on struggling healthcare budgets.

PET and SPECT imaging are well established techniques within nuclear imaging, and are the main focus of this report PET imaging uses Positron Emitting radioactive tracers with a short half life, to image metabolically active organs PET combined with CT allows precise anatomical imaging of the body, identifying diseased areas depending upon the tracer used PET/CT is most often used for cancer diagnosis PET/MRI is a new technique that was introduced to reduce patient exposure to radiation PET only systems are now generally considered obsolete, due to the superior imaging quality of PET/CT

Key Topics Covered:

1 Tables & Figures

2 Introduction

3 Competitive Assessment

3.1 Overview

3.2 Dedicated PET Systems

3.3 PET/CT Systems

3.4 PET/MRI Systems

3.5 Dedicated SPECT Systems

3.6 SPECT/CT Systems

3.7 PET/Ultrasound and SPECT/Ultrasound Systems

4 Pipeline Assessment

4.1 Overview

4.2 Pipeline by Phases in Development

4.3 Product Profiles

4.3.1 Brain Biosciences CerePET

4.3.2 ECORAD Dual Modality Imager

4.3.3 FMI Technologies ScintiStar PET/CT

4.3.4 IntraMedical Imaging Marginator Beta Camera

4.3.5 INSERT SPECT/MRI

4.3.6 Nucare/Zecotek Photonics New Generation PET Scanning Device

4.3.7 Philips Healthcare PET Alpha Ring Detector

4.3.8 Photo Diagnostic Systems NeuroPET/CT

4.3.9 SynchroPET Breast PET/MRI

4.3.10 SynchroPET Wrist Scanner

4.3.11 SurgicEye SPECT Hybrid

5 Clinical Trials to Watch

6 Current and Future Players

6.1 Overview

6.2 Trends in Corporate Strategy

6.3 Company Profiles

7 Appendix

Companies Mentioned

  • DDD-Diagnostic
  • Digirad
  • GE Healthcare
  • GVI Medical Devices
  • Mediso Medical Imaging Systems
  • NeuroLogica
  • Neusoft Medical Systems
  • NuCare Medical Systems
  • Oncovision
  • Philips Healthcare
  • Shimadzu
  • Siemens Healthcare
  • SurgicEye
  • Toshiba Medical

For more information visit http://www.researchandmarkets.com/research/rlz62q/medipoint

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Medical Devices

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Medical Devices